SATURDAY, DECEMBER 3, 2016

Infectious Disease Research Institute

1616 Eastlake Avenue East
Seattle, WA - 98102

Infectious Disease Research Institute News

TB vaccine candidate trial begins in South Africa

The Infectious Disease Research Institute (IDRI) and Wellcome Trust announced that they have started the Phase 2a trial of a tuberculosis (TB) vaccine candidate in South Africa. Read More »

TB vaccine candidate trial begins in South Africa

The Infectious Disease Research Institute (IDRI) and Wellcome Trust recently announced that the organizations have started Phase 2a trial of a tuberculosis (TB) vaccine candidate in South Africa. Read More »